YahooAugust 20, 2026 at 1:54 PM NY15 days ago

Pfizer Stock Is A Race Between New Drugs And Old Patents

The medicines Pfizer has launched and acquired are arriving at close to the scale of the revenue its expiring patents will take away.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Companies in This Story